Eli Lilly plans $3 billion investment in Pleasant Prairie facility
Eli Lilly and Company said Thursday it plans a $3 billion expansion of a drug manufacturing facility in Pleasant Prairie, adding 750 high-skilled jobs to the current 100-plus workforce at the site.
To access this content, you must purchase a Premium membership, or log in if you are a member.
